A number exacerbated by the low sensitivity and yield of traditional diagnostic methods.
Current pathogen detection methods can fail to provide accurate and timely microbial data, essential for understanding microbial dynamics, developing targeted therapies, and identifying emerging threats.
A more sensitive and comprehensive microbiological test is needed to improve research capabilities and clinical outcomes.
Despite its promise, mNGS presents challenges because microbes constitute only a tiny fraction of the genomic material in a sample.
Host, reagent, and environmental contaminants overwhelm microbial signals, leading to decreased detection sensitivity, increased workflow complexities, and higher costs.
That’s why we develop the products that systematically remove the barriers to mNGS adoption from specimen collection to definitive action, empowering you to quickly and easily implement mNGS.
A number exacerbated by the low sensitivity and yield of traditional diagnostic methods.
Current pathogen detection methods can fail to provide accurate and timely microbial data, essential for understanding microbial dynamics, developing targeted therapies, and identifying emerging threats.
A more sensitive and comprehensive microbiological test is needed to improve research capabilities and clinical outcomes.
Despite its promise, mNGS presents challenges because microbes constitute only a tiny fraction of the genomic material in a sample.
Host, reagent, and environmental contaminants overwhelm microbial signals, leading to decreased detection sensitivity, increased workflow complexities, and higher costs.
That’s why we develop the products that systematically remove the barriers to mNGS adoption from specimen collection to definitive action, empowering you to quickly and easily implement mNGS.
Accurate:
Improves microbial reads with integrated host depletion.
Accelerated:
Delivers results in under 24 hours.
Adaptable:
Accommodates a wide range of sample types and applications.
Affordable:
Reduces sequencing depth and costs.
Automatable:
Boosts efficiency with companion
instrumentation.
All-in-One:
Reduces sequencing depth and costs.
Improves microbial reads with
integrated host depletion.
Delivers results in
under 24 hours.
Accommodates a wide range of
sample types and applications.
Reduces sequencing
depth and costs.
Boosts efficiency with companion
instrumentation.
A single solution for all types
of microorganisms.
Evaluation of a mNGS Assay with Novel Host Depletion Method for Pathogen Identification in Septic Patients
03.28.2023
Emerging Infectious Diseases in Thailand Highlight Need for Advanced Diagnostic Solutions
09.24.2024
Integrating mNGS into Clinical Practice – Challenges and Opportunities
Taipei, Taiwan (TaiNex1)
December 6, 2024
The Hidden Crisis in Infectious Disease Diagnostics: When Tests Fail to Identify the Causal Pathogen
September 2024
Micronbrane Medical technologies enrich our understanding of microorganisms through innovative metagenomic collection devices, novel host depletion, mNGS-grade reagents, advanced metagenomic sequencing assays, automation instrumentation, plus rapid bioinformatic software.
© 2024 Micronbrane Medical